Rusfertide for the treatment of iron overload in HFE-related haemochromatosis: an open-label, multicentre, proof-of-concept phase 2 trial

Autor: Kowdley, Kris V *, Modi, Nishit B, Peltekian, Kevork, Vierling, John M, Ferris, Christopher, Valone, Frank H, Gupta, Suneel
Zdroj: In The Lancet Gastroenterology & Hepatology December 2023 8(12):1118-1128
Databáze: ScienceDirect